Home   Contact Palatin   Site Map  
 

Investor/Media Center

Press Releases

 
2008 2009 2010 2011 2012 2013 2014 all
 
 

 


Displaying releases: 1-40 | 41-80 | 81-120 | 121-160 | 161-197


  Nov-12-2012 Palatin Technologies, Inc. To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
  Nov-09-2012 Palatin Technologies, Inc. To Report Fiscal Year 2013 First Quarter Results; Teleconference and Webcast to be held on November 14, 2012
  Nov-08-2012 Palatin Technologies Reports Positive Results for Phase 2B Bremelanotide Female Sexual Dysfunction Trial
  Sep-11-2012 Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2012 Results
  Sep-10-2012 Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
  Sep-07-2012 Palatin Technologies Provides Update Regarding Its Obesity Research/Development Collaboration with AstraZeneca
  Sep-06-2012 Palatin Technologies, Inc. To Report Fiscal Year 2012 Fourth Quarter Results; Teleconference and Webcast to be held on September 11, 2012
  Jul-02-2012 Palatin Technologies, Inc. Announces Pricing of $35 Million Private Placement of Common Stock and Warrants
  Jun-19-2012 Palatin Technologies Announces Halting of Phase I Clinical Trial of Obesity Compound in AstraZeneca Research Collaboration
  May-14-2012 Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on May 14, 2012
  May-08-2012 Palatin Technologies, Inc. To Report Fiscal Year 2012 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2012
  Apr-19-2012 Palatin Technologies Announces First Patient Dosed in Second Phase I Clinical Trial of Obesity Compound from Research Collaboration
  Mar-08-2012 Palatin Technologies Completes Enrollment in Phase 2B Bremelanotide Female Sexual Dysfunction Trial
  Mar-07-2012 PALATIN TECHNOLOGIES, INC. TO PRESENT AT THE 24th ANNUAL ROTH OC GROWTH STOCK CONFERENCE
  Feb-15-2012 Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on February 15, 2012
  Feb-09-2012 PALATIN TECHNOLOGIES TO PRESENT AT 14TH ANNUAL BIO CEO & INVESTOR CONFERENCE
  Feb-08-2012 Palatin Technologies, Inc. To Report Fiscal Year 2012 Second Quarter Results; Teleconference and Webcast to be held on February 15, 2012
  Jan-17-2012 Palatin Technologies Receives $1.1 Million from Sale Of New Jersey State Tax Credits
  Jan-16-2012 Palatin Technologies to Present at BOCEMb, Noble Financial Capital Markets' Eighth Annual Equity Conference
  Nov-30-2011 Palatin Technologies to Present at Windhover's Therapeutic Area Partnerships Conference
  Nov-15-2011 Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
  Nov-10-2011 Palatin Technologies, Inc. To Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
  Oct-21-2011 PALATIN TECHNOLOGIES TO PRESENT AT 10TH ANNUAL BIO INVESTOR FORUM
  Sep-22-2011 Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2011 Results
  Sep-19-2011 Palatin Technologies, Inc. To Report Fiscal Year 2011 Fourth Quarter Results; Teleconference and Webcast to be held on September 22, 2011
  Sep-09-2011 Palatin Technologies, Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference
  Aug-04-2011 Palatin announces commencement of a Phase 1 Trial for Obesity Compound in collaboration with AstraZeneca
  Jun-28-2011 Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial with Bremelanotide in Women with Female Sexual Dysfunction
  Jun-23-2011 Alan Dunton, M.D., Joins Board of Directors of Palatin Technologies, Inc.
  Jun-21-2011 Palatin Technologies, Inc. Issued U.S. Patent for Key Component in PL-3994 Drug Candidate
  Jun-15-2011 Palatin Technologies, Inc. Announces Presentation and Publication on Validation of Scale for Subjective Male Sexual Arousal
  May-16-2011 Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2011 Results
  May-12-2011 Palatin Technologies, Inc. March 31, 2011 Quarter Results; Teleconference and Webcast to be held on May 16, 2011
  May-11-2011 Palatin Technologies, Inc. Announces Results of Annual Stockholders’ Meeting
  Mar-09-2011 Palatin Technologies, Inc. to Present at the ROTH 23rd Annual OC Growth Stock Conference
  Mar-03-2011 FDA Clears Palatin Technologies’ IND Filing To Commence Clinical Studies for Asthma
  Mar-01-2011 Palatin Technologies, Inc. Closes $23 Million Public Offering
  Feb-24-2011 Palatin Technologies, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
  Feb-23-2011 Palatin Technologies, Inc. Announces Proposed Public Offering of Common Stock and Warrants
  Feb-18-2011 Palatin Technologies, Inc. December 31, 2010 Quarter Results; Teleconference and Webcast to be held on February 24, 2011